Canaccord Genuity Group reissued their buy rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research note published on Tuesday morning, Benzinga reports. Canaccord Genuity Group currently has a $11.00 price objective on the stock. Other equities research analysts have also recently issued research reports about the stock. Guggenheim upgraded shares of […]
Health Catalyst (NASDAQ:HCAT – Free Report) had its target price lowered by Canaccord Genuity Group from $12.00 to $11.00 in a report issued on Friday morning, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other brokerages have also weighed in on HCAT. Stifel Nicolaus dropped their price objective on […]
Evercore ISI Trims Health Catalyst (NASDAQ:HCAT) Target Price to $10 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) have been given an average recommendation of “Moderate Buy” by the thirteen research firms that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average […]
Analysts Set Health Catalyst, Inc (NASDAQ:HCAT) Price Target at $13 42 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.